Summit Therapeutics

Summit Therapeutics FCF Margin

The Free Cash Flow Margin of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -5,943.66 %. In the previous year, Free Cash Flow Margin was -4,027.62 % — a change of 47.57% (lower).

FCF Margin

-5,943.66 %

YoY

47.57%

Last updated:

Free Cash Flow Margin of Summit Therapeutics is 2022 -5,943.66 % . Free Cash Flow Margin of Summit Therapeutics was 2021 -4,027.62 % . It decreases by 47.57% lower compared to the previous year.

The Summit Therapeutics FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2016
523.91 USD
Jan 1, 2017
-138.63 USD
Jan 1, 2018
-61.78 USD
Jan 1, 2019
-2,851.35 USD
Jan 1, 2020
-5,643.02 USD
Jan 1, 2021
-4,027.62 USD
Jan 1, 2022
-5,943.66 USD
The Summit Therapeutics FCF Margin history
YEARFCF MarginYoY
-5,943.66 %+47.57%
-4,027.62 %-28.63%
-5,643.02 %+97.91%
-2,851.35 %+4,515.36%
-61.78 %-55.44%
-138.63 %-126.46%
523.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Free Cash Flow Margin of Summit Therapeutics is -5,943.66 % in 2022.

Free Cash Flow Margin of Summit Therapeutics changed from -4,027.62 % to -5,943.66 %, representing a 47.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Summit Therapeutics

All Key Metrics — Summit Therapeutics